Search results
Advisory Panel Votes Against Once-Weekly Insulin for T1D
Medscape· 17 hours agoFood and Drug Administration (FDA) determined that the potential benefits of the investigational...
Semaglutide Significantly Improves Chronic Kidney Disease
Medscape· 2 days ago"This is the first trial that's specifically asked the question of whether this class of drugs —...
Will FDA Advisors Look Past Hypoglycemia Risk With Once-Weekly Insulin?
MedPage Today· 4 days agoIn the phase IIIa ONWARDS 6 trial, insulin icodec was just as efficacious -- but not superior to --...
Losing Muscle with GLP-1 RAs? There May be a Drug for That
Medscape· 2 days agoMedications in development would preserve muscle mass and augment fat loss when used in combination...
Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD
MedPage Today· 2 days agoPhase III trial adds a fourth class shown to benefit this population
Does Daytime Hypoglycemia Contribute to Impaired Awareness?
Medscape· 5 days agoIn older adults with T1D, less daytime hypoglycemia was the biggest predictor of improvements in IAH...
Many people quit new weight-loss drugs because of costs, side effects
UPI· 2 days agoReasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side...
Food Insecurity Quadruples Severe Hypoglycemia Risk in T2D
Medscape· 5 days agoBoth financial and physical food insecurity increased the risk, but standard questions didn't...
What Is the Strongest Weight Loss Prescription Pill?
MediaFeed via AOL· 3 days agoWondering what’s the strongest weight loss prescription pill? If you came here expecting a one-size-fits-all answer, we have bad news. The term...
Newtopia Reports Fourth Quarter, Full Year 2023 and First Quarter 2024 Financial Results
WFRV 5 Green Bay· 2 days agoGrowth of GLP-1s opens a huge market for Newtopia to demonstrate sustainability and ROI. Rise of Health AI and next-gen clinical discovery requires Newtopia's novel data and capabilities. TORONTO ...